Comment on: Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 week controlled trial

Rheumatology (Oxford). 2008 Mar;47(3):381-2; author reply 382-3. doi: 10.1093/rheumatology/kem381. Epub 2008 Jan 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atorvastatin
  • Controlled Clinical Trials as Topic
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiology
  • Female
  • Follow-Up Studies
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy*
  • Male
  • Pyrroles / therapeutic use*
  • Treatment Outcome
  • Vasodilation / drug effects*
  • Vasodilation / physiology

Substances

  • Heptanoic Acids
  • Pyrroles
  • Atorvastatin